Forensic Genomics Firm Othram Raises $4M

Mar 12, 2019

|

NEW YORK (GenomeWeb) — Forensic genomics startup Othram said today that it has raised $4 million in Series A financing. Nimble Ventures, a San Francisco-based venture capital firm, led the round.

Othram said it has also been awarded a $10,000 research sequencing grant from Illumina Accelerator, Illumina's business incubator.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Treatment So Far

NPR reports that the patient who underwent a CRISPR-based treatment for sickle cell disease is doing well.

Resistance to Ash Dieback Disease

Resistance to ash dieback disease among some UK ash trees appears polygenic, the Independent reports.

Nucleic Acids Research Papers on FIN-Seq, ChlamDB, BBCancer

In Nucleic Acids Research this week: sequencing strategy for flash-frozen brain tissue bank samples, new version of ChlamDB, and more.

Lawsuit on Not Knowing Father's Test Result

A UK woman is suing three National Health Service Trusts for not telling her about her father's Huntington's disease diagnosis, the BBC reports.

Featured White Papers

The Importance of Coverage Uniformity Over On-Target Rate for Efficient Targeted NGS

Independent, Third-Party Studies Evaluating the Efficiency of the Twist Human Core Exome Kit for Target Sequencing

KAPA RNA HyperPrep: A Streamlined Library Preparation Workflow that Enables Robust Gene Expression Profiling Using RNA-sequencing

Orthogonal Methods for Validation and Confirmation of Next-Generation Sequencing Results

Dec

02

Featured Webinar

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of   FLT3  and  CEBPA

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

Dec

04

Featured Webinar

Integrating Genetic Data in Clinical Workflows: How CCPM Established a Personalized Health Framework

This webinar will discuss what it takes to begin realizing precision medicine in a comprehensive clinical infrastructure, with insights from the Colorado Center for Personalized Medicine (CCPM).

Dec

10

Featured Webinar

Maximizing Diagnostic Yield with an Optimized Variant Interpretation Platform

This webinar will discuss the use of next-generation sequencing and an optimized variant interpretation workflow to increase diagnostic yield in complex clinical cases.

Dec

11

Featured Webinar

Advances in Precision Oncology: Tertiary Analysis Software for Solid Tumor NGS

This webinar will address how two molecular laboratories are implementing tertiary analysis software to improve their precision oncology workflows.

Menu

Forensic Genomics Firm Othram Raises $4M

To read the full story....

Breaking News

GenapSys Raises $90M in Series C Round, Launches Sequencer in US

Beckman Coulter, IncellDx Form Cancer Assay Promotion Agreement

T2 Biosystems Gets CE Mark for Direct-From-Blood Antimicrobial Resistance Panel

Cancer Genetics' Discovery Services Drive Q3 Revenue Gains

XD Bio Gets $150K NHGRI Grant to Develop Web Interface for ENCODE Project

Fluidigm to Issue $45M of Convertible Senior Notes

The Scan

Treatment So Far

Resistance to Ash Dieback Disease

Nucleic Acids Research Papers on FIN-Seq, ChlamDB, BBCancer

Lawsuit on Not Knowing Father's Test Result

Featured White Papers

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of   FLT3  and  CEBPA

Integrating Genetic Data in Clinical Workflows: How CCPM Established a Personalized Health Framework

Maximizing Diagnostic Yield with an Optimized Variant Interpretation Platform

Advances in Precision Oncology: Tertiary Analysis Software for Solid Tumor NGS

What's Popular?

Cancer Diagnostics Firm Lucence Raises $20M

Personalis, Merck KGaA to Study Cancer Biomarkers Using Immunogenomics Platform

Despite FDA Clearance for NantHealth Test, Benefits of TMB Biomarker Unclear

Paragon Genomics Discusses New Gene Fusion Detection Method, Cystic Fibrosis Panel

Illumina Proposes Opening PacBio IP to Competitors to Save Acquisition Deal

Sponsorships